Madrigal reported better-than-expected Q4 results. The company also announced positive new two-year data from a phase 3 study of its MASH drug Rezdiffra. Madrigal reported fourth-quarter revenue ...

Madrigal Pharmaceuticals, Inc.'s Rezdiffra, the first approved drug for MASH, showed strong sales growth, with Q4 net sales up 66% to $103.3m. Despite a net loss of $466m in 2024, Madrigal's cash ...

Nick Madrigal dislocated his left shoulder during today’s Spring Training split-squad game between the Mets and Nationals. In the first inning of the game, Madrigal (who was playing shortstop ...

Some of your TikTok feeds might feature the content of Kim Raymond “Ray” Feaste , a Black man who is often seen living his best life with his pet monkey, Thabo. However, the creator claims he ...

WEST CONSHOHOCKEN, Pa. (AP) — WEST CONSHOHOCKEN, Pa. (AP) — Madrigal Pharmaceuticals Inc. (MDGL) on Wednesday reported a loss of $59.4 million in its fourth quarter. The West Conshohocken ...

Shares of Madrigal Pharmaceuticals (NASDAQ: MDGL) were soaring 15.2% higher as of 11:05 a.m. ET on Wednesday. The big gain came after the small biopharmaceutical company announced its fourth ...

PORT ST. LUCIE — Nick Madrigal won’t be an option for the Mets anytime soon. The infielder, according to manager Carlos Mendoza, has been diagnosed with a fracture to his left shoulder ...

WEST PALM BEACH, Fla. -- New York Mets infielder Nick Madrigal dislocated his non-throwing shoulder Sunday in a spring training game against the Washington Nationals. Madrigal is fighting for a ...

On Sunday, in a split-squad game against the Washington Nationals, utility infielder Nick Madrigal exited the contest in the bottom of the first inning; he had only been in the field for six batters.

Nick Madrigal, a utility infielder who came into camp with a good chance of making the Mets out of spring training, suffered a fractured left shoulder in Sunday’s split-squad game against the ...

Madrigal posted a Q4 loss of $2.71 per share, beating estimates, with sales of $103.22 million surpassing the $98.56 million consensus. Our government trade tracker caught Pelosi’s 169% AI winner.